loading page

Autoimmunity and Antibody Dependent COVID-19 Enhancement of SARS CoV-2 Vaccination: A Global Human Right to Know then Decide.
  • Mina Kelleni
Mina Kelleni
Author Profile


mRNA based and adenovirus vectored vaccines, were first ever or first commercially ever approved for the public, respectively. However, these new types possess a potential risk to induce auto-immune diseases e.g., thrombocytopenia and some of these complications might also reason for some of the post vaccination sudden death reports e.g., autoimmune myocarditis and immune induced thrombosis and thromboembolism. Moreover, all SARS CoV-2 types of vaccines, depending on the spike protein immunogenicity, especially the conventional inactivated ones might increase the likelihood of COVID-19 severity upon re-infection through antibody dependent enhancement which might reason for the recently described abundance of hospital admissions within seven days of vaccination and might also reason for some of the serious adverse effects encountered with administration of convalescent plasma to COVID-19 patients. Furthermore, SARS CoV-2 vaccines might share in development of some lethal SARS CoV-2 variants. Finally, we suggest that making these COVID-19 vaccines compulsory is a crime against humanity and an informed personalized risk benefit ratio especially for described high risk groups must be secured.